Infusion Services

OPA offers a wide variety of infusion services in a comfortable, semi-private infusion room complete with heated massage chairs, warm blankets, and privacy curtains. Port access and ultrasound-guided vascular access available for patients with difficult to access veins. Cortisol stimulation tests are also available. Patients receive compassionate care and expertise from On-site rheumatologists and nurses with Oncology Nursing Society Biotherapy & Chemotherapy certifications.

Infusion Treatments Include:

• Actemra® (Tocilizumab) Treats moderate to severe rheumatoid arthritis.
• Benlysta® (Belimumab) Treats systemic lupus erythematosus.
• Cimzia (certolizumab) Treats rheumatoid arthritis, Chron’s disease, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, non-radiographic axial spondylarthritis
• Cosentyx treats psoriatic arthritis, ankylosing spondylitis,  and non-radiographic axial spondyloarthritis
• Entyvio (vedolizumab) Treats ulcerative colitis, Crohn’s disease
• Evenity (romosozumab) Treats osteoporosis in women
• Iron Replacement (Injectafer/Venofer/Monoferric) Treats iron deficiency anemia
• IVIG treats Primary Immune Deficiency-PI, chronic Inflammatory demyelinating polyneuropathy-CIDP, idiopathic thrombocytopenia purpura-ITP
• Krystexxa® (Pegloticase) Treats tophaceous gout.
• Nucala (mepolizumab) Treats eosinophilic granulomatosis with polyangitis, moderate to severe eosinophilic asthma, nasal polyps, hypereosinoplilic syndrome
• Nulojix (belatacept) prevents transplant rejection in kidney transplant patients
• Orencia® (Abatacept) Treats moderate to severe rheumatoid arthritis (RA) in adults who have taken other medicines for RA.
• Prolia (denosumab) Treats osteoporosis
• Reclast® (Zoledronic acid) Treats osteoporosis.
• Remicade® (Infliximab) Treats rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn disease, plaque psoriasis, and ulcerative colitis.
• Rituxan® (Rituximab) Treats rheumatoid arthritis, Wegener’s granulomatosis.
• Saphnelo (anifroluman-fnia) Treats systemic lupus erythematosus
• Simponi® Aria™ (Golimumab) Treats moderate to severe rheumatoid arthritis in adults.
• Skyrizi Treats Plaque Psoriasis/ Psoriatic Arthritis and Cronhs disease
• Soliris (Eculizumab): Treats paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, myasthenia gravis, neuromyelitis optica spectrum disorder
• Solu-Medrol® (Methylprednisolone) Treats acute autoimmune disease flare.
• Stelara (ustekinumab) treats psoriatic arthritis, Crohn’s disease, ulcerative colitis
• Tepezza (Teprotumumab) Treats thyroid eye disease
• Ultomiris (ravulizumab-cwvz) Treats paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome
• Xolair (omalizumab) Treats moderate to severe asthma, chronic hives, nasal polyps

Please note that all rheumatology and infusion services require referral from a primary care provider.